SCHEMBL11304378

SCHEMBL11304378

CC(CN(c1ccc(C(=O)NO)cc1)C1CCNC1=O)c1cccc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 6/20 0.38
▸ HDAC8 Q9BY41 4/20 0.38
▸ HDAC1 Q13547 5/20 0.38
▸ HDAC4 P56524 2/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ ADRA2A P08913 1/20 0.36
▸ ADRA2B P18089 1/20 0.36
▸ ADRA2C P18825 1/20 0.36
▸ CASR P41180 5/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ SSTR4 P31391 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301466 0.85 HDAC1 (0.44) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11300531 0.84 HDAC1 (0.42) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11294962 0.82 HDAC6 (0.40) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11296122 0.78 HDAC6 (0.43) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11300775 0.74 HDAC1 (0.50) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11301463 0.73 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11301136 0.73 ROCK2 (0.42) —
SCHEMBL11300527 0.73 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11304336 0.72 HDAC6 (0.42) HDAC6HDAC8HDAC1HDAC4HDAC3
SCHEMBL11304346 0.71 CA1 (0.48) HDAC6HDAC8HDAC1HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback